Facebook Linkedin RSS Twitter Youtube
Home 2025

Government policy making

JPM: More “Smaller, Smarter” M&A Deals Expected in 2025, EY Predicts
GEN Edge

JPM: More “Smaller, Smarter” M&A Deals Expected in 2025, EY Predicts

Navigating the Regulatory and Manufacturing Realities of mRNA Therapeutic Development
Bioprocessing

Navigating the Regulatory and Manufacturing Realities of mRNA Therapeutic Development

Seven Biopharma Trends to Watch in 2025
GEN Edge

Seven Biopharma Trends to Watch in 2025

Gene Signature for High-Risk Form of Acute Lymphoblastic Leukemia Identified by CHOP Scientists
Cancer

Gene Signature for High-Risk Form of Acute Lymphoblastic Leukemia Identified by CHOP Scientists

Trump to Nominate Makary for FDA Commissioner
Drug Discovery

Trump to Nominate Makary for FDA Commissioner

StockWatch: Moderna Seeks to Reassure Investors on RFK Jr.
Drug Discovery

StockWatch: Moderna Seeks to Reassure Investors on RFK Jr.

StockWatch: Vaccine, ETF Shares Drop as Trump Chooses RFK Jr. for HHS
Drug Discovery

StockWatch: Vaccine, ETF Shares Drop as Trump Chooses RFK Jr. for HHS

Treehill CEO Sees Positives for Biopharma in Trump’s Re-Election
Drug Discovery

Treehill CEO Sees Positives for Biopharma in Trump’s Re-Election

StockWatch: Wall Street Weighs Trump Effect on Biopharma, from Vaccines to M&A
Drug Discovery

StockWatch: Wall Street Weighs Trump Effect on Biopharma, from Vaccines to M&A

StockWatch: Sangamo Shares Surge on Shorter Pathway for Fabry Candidate
GEN Edge

StockWatch: Sangamo Shares Surge on Shorter Pathway for Fabry Candidate

123...21Page 1 of 21
Copyright © 2025 Genetic Engineering & Biotechnology News. All Rights Reserved.